Evidence map›Paper›PMID 41929277›Full record

ArticleFrontiers in veterinary science2026

A systems pharmacology-based

Siting Pu, Lihui Zhang, Hongzao Yang, Guangming Wang, Tingting Liu, Hongwei Chen, Wei Wei

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siting Pu *College of Veterinary Medicine, Southwest University, Chongqing, China.
Lihui Zhang *School of Pharmaceutical Sciences, Tongren Polytechnic University, Guizhou, China.
Hongzao YangCollege of Veterinary Medicine, Southwest University, Chongqing, China.
Guangming WangCollege of Veterinary Medicine, Southwest University, Chongqing, China.
Tingting LiuCollege of Veterinary Medicine, Southwest University, Chongqing, China.
Hongwei ChenCollege of Veterinary Medicine, Southwest University, Chongqing, China.
Wei WeiCollege of Veterinary Medicine, Southwest University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Avian salmonellosis is a major bacterial disease affecting the poultry industry. With increasing restrictions on antibiotic use in animal husbandry, alternative strategies for disease prevention are urgently required. Traditional Chinese medicine, characterized by a low risk of antimicrobial resistance, represents a promising alternative for sustainable livestock production. Methods: First of all, Pulsatillae radix‌ and six additional medicinal herbs were combined to formulate Wengxian granules, and their protective effects against avian salmonellosis were assessed. Then a systems pharmacology-based method integrating main active components screening, target prediction, network analyses, GO and KEGG analyses were used for the systematic deciphering of the mechanism of Wengxian granules in avian salmonellosis. Finally, based on systems pharmacology results, molecular docking was performed using AutoDock software. Results: Following Salmonella infection, the model group exhibited increased white and red blood cell counts and a reduced lymphocyte ratio compared with the control group. Severe detachment of the cecal mucosal layer was observed in the model group. Treatment with Wengxian granules significantly reversed these alterations by decreasing white and red blood cell counts and restoring the lymphocyte ratio, and protecting the integrity of the cecal mucosa and lamina propria. Immunological analysis showed that IgM, IgG and sIgA levels were elevated in the model group after infection, whereas Wengxian granule treatment reduced these levels. At the end of the experiment, immunoglobulin levels were significantly decreased in the model group compared with controls, whereas no significant differences were observed among the Wengxian-treated groups. Network pharmacology analysis identified 40 active compounds and 66 potential therapeutic targets associated with Wengxian granules. Kaempferol, β-sitosterol, quercetin, and hesperetin were identified as key bioactive components. KEGG pathway enrichment highlighted the Toll-like and NOD-like receptor signaling pathways as major pharmacological mechanisms involved. Molecular docking further confirmed stable interactions between core targets and active compounds. Discussion: Overall, these findings indicate that Wengxian granules exert protective effects against avian salmonellosis and provide mechanistic insights into their potential application as a non-antibiotic therapeutic strategy.

Indexed as

immunitymolecular dockingnetwork pharmacologypharmacological mechanismSalmonella

Identifiers

PMID41929277
PMCPMC13038521

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.